Beruflich Dokumente
Kultur Dokumente
Review
Febrile children account for 15% of emergency department visits and outcomes range from
the presence of serious bacterial infection to benign self-limited illness.
OBSERVATIONS Studies from 1979 to 2015 examining febrile infants and children were
included in this review. Management of febrile infants younger than 90 days has evolved
considerably in the last 30 years. Increased rates of Escherichia coli urinary tract infections,
increasing resistance to ampicillin, and advances in viral diagnostics have had an effect on the
approach to caring for these patients. Widespread vaccination with conjugate vaccines
against Haemophilus influenzae and Streptococcus pneumoniae has virtually eliminated the
concern for bacterial infections in children aged 3 to 36 months. Urinary tract infections still
remain a concern in febrile infants of all ages.
CONCLUSIONS AND RELEVANCE Advances over the last 30 years allow for more precise risk
stratification for infants at high risk of serious bacterial infection. With appropriate testing at
the initial visit, much of the diagnostic testing and empirical treatment can be avoided for
infants younger than 90 days. In the vaccinated child aged 3 to 36 months, the only bacterial
infection of concern is urinary tract infection.
JAMA Pediatr. doi:10.1001/jamapediatrics.2016.0596
Published online June 20, 2016.
dren developed invasive infections, including pneumonia, osteomyelitis, and meningitis, but most had treatment outcomes that were
benign.5,6 The concern for occult bacteremia and the risk of subsequent associated morbidity led many health care professionals to
obtain blood cultures and start empirical antibiotics in children with
fever without focal examination findings.2,7 With widespread use of
the Hib vaccine, Hib bacteremia nearly disappeared.8,9 Subsequent 7-valent and 13-valent conjugate vaccines for S pneumoniae
led to greater than 50% reductions in S pneumoniaerelated
bacteremia.10 As a result, occult bacteremia has also disappeared.11-13
Routine vaccination against Hib and S pneumoniae also resulted in decreased incidence of bacterial meningitis. After routine
use of the Hib vaccine, the incidence of Hib meningitis decreased
by 99% in children younger than 5 years.14 Subsequently, the development of the pneumococcal vaccines decreased the incidence
of meningitis caused by S pneumoniae considerably. Castelblanco
et al15 describe an 83% decreased incidence between 1997 and 2010.
Olarte et al16 describe continued reductions in S pneumoniae meningitis from 2010 to 2013 with the switch from 7-valent to 13-valent
pneumococcal conjugate vaccine.
Although not directly owing to vaccination, rates of infection
with Neisseria meningitidis have also declined to historically low
levels.17 Although this pathogen was never the most prevalent, meningococcal bacteremia was most likely to lead to meningitis and
many clinicians experienced cases in the past in which children with
fever discharged from the emergency department returned in shock.
(Reprinted) JAMA Pediatrics Published online June 20, 2016
E1
Management Recommendations
Children in this age group with fever, evidence of viral illness, and/or
normal findings from the urinalysis do not require empirical therapy.
In patients with localizing signs of infection (otitis media, skin and
soft-tissue infections, enteritis, and pneumonia), evaluation should
be guided by the presenting symptoms. These infections rarely occur without signs and symptoms, particularly in patients older than
3 months. For children with fever without localizing signs of infection, given that the odds of identifying a contaminant is 100 times
more likely than identifying a true pathogen, management has
moved away from evaluation of complete blood cell counts, blood
cultures, and empirical antibiotics of any kind.11-13
When managing a child who has received fewer than 2 doses
each of Hib and S pneumoniae vaccines, management reverts to the
more comprehensive evaluation of complete blood cell counts, blood
cultures, and sometimes examinations of cerebrospinal fluid. The
same guidance applies for children with immune deficiencies, acquired or hereditary, as they are overrepresented among patients
with S pneumoniae bacteremia.30,31 These children also warrant
evaluation for bacteremia or other SBI.
underlying pathologic conditions such as vesicoureteral reflux or urinary tract anomalies. The most recent revision of the American Academy of Pediatrics guidelines for management of UTIs with fever acknowledges the importance of evaluating children with fever without
localizing symptoms by conducting urinalysis and urine culture before administration of antibiotics.29 In addition, they advise performing renal ultrasonography to evaluate for anatomical anomalies requiring surgical intervention.
Although overall risk for SBI is increased in infants younger than
3 months compared with older infants, there is variation in risk among
this age group as well. Infants younger than 28 days are at higher
risk of SBI than infants aged 28 to 90 days.37-39 Historically, guidelines have acknowledged this increased risk and treated neonates
more conservatively.
Although the mechanism of relative immunodeficiency of the
neonate is unknown, immaturity of T-cell function may play a significant role. Reproducible evidence demonstrates that neonatal
T-cells express significantly less CD40 ligand than do T-cells from
older individuals. CD40 is critical in communication between
T-cells and B-cells that promote antibody class switching in response to antigenic insult, and the deficiency may partially account for the increased neonatal susceptibility to infection.40-43
Although some infants with SBI will appear very ill (toxic), many
present without localizing signs of infection. Owing to concern about
not identifying SBI in infants younger than 3 months, it had been common practice to admit all febrile patients aged 8 weeks or younger,
obtain laboratory evaluation and blood cultures, and treat them empirically for SBI.5,44,45 This practice decreases the risk of failing to treat
infants with a potentially serious illness, but comes with significant
cost and potential complications.
Researchers have continued to investigate better methods of
identifying infants at high risk of SBI and decreasing unnecessary
treatment and hospitalization of those at low risk. One of the first
studies to establish clinical predictors of risk of SBI in infants younger
than 3 months, published in 1985, outlined what became known as
the Rochester criteria.4 Infants were considered low risk if they were
well appearing, did not have evidence of focal infection, and met the
following criteria: white blood cell count of 5 to 15 000/L, with less
than 1500 bands/L (to convert to 109/L, multiply by 0.001) and
normal urinalysis findings. A total of 144 of 233 infants (61.8%) met
low-risk criteria for SBI, and of these, 1 (0.7%) had an SBI, compared with 22 of 89 infants (25%) classified as high risk.
The Rochester criteria continue to be used by many health care
professionals because, even though they do not rely on cerebrospinal fluid parameters, their negative predictive value is 99%.4 A major limitation of the Rochester criteria is that they included only fullterm infants with no significant medical history. For premature infants
or infants with medical conditions, modified criteria (Boston criteria46
and Philadelphia criteria47) are available for those presenting after
28 days of life (Table). In 1993, Baraff et al45 offered expert opinion
recommending a complete evaluation for sepsis, including blood culture, urine culture, and lumbar puncture, followed by admission for
empirical antibiotic treatment for all infants with fever younger than
28 days. These recommendations were used as guidelines by many
but were not endorsed as policy until the American College of Emergency Physicians reiterated this recommendation in 2003.48
There is significant variation among inpatient and outpatient clinicians who evaluate and treat neonates with fever. Pantell et al39
jamapediatrics.com
Rochester4
Philadelphia47
Boston46
Benefits
Drawbacks
Low-risk criteria
published the Pediatric Research in Office Settings study documenting equivalent outcomes for febrile infants who were managed conservatively in office-based settings. A recent retrospective review
across 36 pediatric emergency departments demonstrated that
369 of 2253 neonates with fever (16.4%) were discharged from
the emergency department, with only 1 patient (0.3%) returning
with SBI.49 The ability to assess risk in neonates continues to be
controversial.50-53 Just as much variation exists in the treatment of
patients admitted for evaluation for sepsis, where choice of antibiotics and duration of treatment vary widely between institutions and
among clinicians. Although some clinicians are comfortable observing the patient for 24 hours, others require 72 hours for stable infants who have negative blood culture results before discontinuing
antibiotics. Recent evidence indicates that if pathogenic bacteria are
present, 96% of blood culture results become positive by 36 hours
and 91% are positive by 24 hours.54 Observation for 36 hours while
receiving antibiotics should be adequate to identify nearly all infants infected with SBI.
Several major changes affecting the management of febrile neonates are worth a detailed discussion: greater understanding of a viral diagnosis and the subsequent risk of SBI, decreased incidence of
early-onset group B streptococcal infection, decreased incidence
of Listeria infection, and subsequent increasing incidence of ampicillin-resistant organisms.
UTIs. These results suggested that once the diagnosis of RSV was
made, the risk of SBI other than UTIs was essentially zero.
Enterovirus is frequently responsible for febrile illness in young
infants, accounting for 40% to 50% of cases during the summer.55
Rittichier et al56 describe a cohort of 214 infants with fever and
enterovirus infection, of whom 12 (5.6%) had concurrent UTI and
3 (1.4%) had bacteremia; most (13 [86.7%]) of the 15 infants with
coexisting SBI were classified as high risk.
The predictive value of influenza and SBI has been investigated in recent years. Studies indicate the rate of SBI in febrile
infants is significantly lower with known influenza infection than in
those negative for influenza.26,57 Analogous to RSV studies, they
confirm very low rates of bacteremia and detectable rates of UTI in
infants with influenza.26,57
With mounting evidence that a confirmed viral infection reduces the risk of SBI, this information has become more codified in
risk stratification criteria. Byington et al25 confirmed evidence that
any viral infection combined with the Rochester criteria further delineates risk of SBI. If results of viral testing are rapidly available, they
can be used with the Rochester criteria to direct the management
of febrile infants. An evaluation algorithm incorporating rapid viral
testing into risk stratification criteria has decreased the length of a
hospital stay, time exposed to antibiotics, and cost.32
In a recent epidemiologic study using new multiplex testing
methods, Byington et al58 reported the prevalence and persistence of respiratory viruses in the general population. Children are
more likely to have positive test results for viral infection in the household, and rates of viral infections increased with the number of children in the household and with decreasing age of children. Most episodes of viral infection detected by PCR persisted for less than
2 weeks, but some viruses were detected by PCR after 3 weeks, well
after symptoms had resolved.58 This finding supports evidence that
most febrile illnesses in children are viral infections but should also
caution health care professionals that not every PCR-positive detection is reliable for management decisions.
E3
trapartum prophylactic antibiotic treatments has decreased incidence of early-onset GBS infection from 1.8 of 1000 live births in
1990 to 0.32 of 1000 live births in 2003.62 However, these efforts
have not changed the incidence of late-onset GBS infection.63 Mothers of infants with late-onset GBS are more likely to be carriers of
GBS at the time of diagnosis than at the time of antenatal screening.63
Although mortality from late-onset GBS is lower than from earlyonset disease, morbidity still involves developmental delay, cerebrovascular changes, hearing loss, or intellectual disability. Empirical treatment for febrile infants who are at high risk of bacterial
infection should continue to cover GBS.
Listeria
Although Listeria infection had been relatively prevalent, with 1.76
cases of perinatal infection per 10 000 children younger than 1 year
in 1989, the incidence has fallen drastically.64 By 1993, surveillance
data indicated the incidence of perinatal listeriosis had decreased
by 51% to 0.86 cases per 10 000 children younger than 1 year. In
the past 10 years, numerous studies examining the causes of neonatal SBI show an absence of Listeria infection in infants younger than
60 days. These studies span the United States and include large academic hospitals and smaller community hospitals.22,27,33,34,37,65-67
We previously hypothesized that widespread use of intrapartum
antibiotics against GBS may have been a contributor to decreased
cases of listeriosis. The Pediatric Health Information Systems database has demonstrated that reductions in rates of listeriosis in infants significantly correlate with decreases in early-onset GBS and
likely represent a collateral benefit.33,68 These results indicate that
Listeria infection is rare in infants; however, most studies represent
retrospective evaluations. Large prospective trials would be necessary to evaluate the true incidence of Listeria infections in the neonatal period.
Ampicillin Resistance
Intrapartum prophylaxis is important in decreasing early-onset GBS,
but the widespread use of ampicillin for prophylaxis has been shown
to increase the risk of early-onset sepsis owing to ampicillinresistant pathogens. Puopolo and Eichenwald69 describe increasing proportions of ampicillin-resistant pathogens cultured from neonates since the widespread use of ampicillin for intrapartum
prophylaxis. The 2 largest risk factors for ampicillin-resistant bacteria were maternal exposure to ampicillin and length of that exposure. The 2010 Centers for Disease Control and Prevention guidelines for intrapartum prophylaxis recommend either penicillin
G potassium or sodium or ampicillin, so use varies based on hospital culture and protocol.59 Infants born to mothers who received prophylaxis with penicillin or other gram-positive agents, such as clindamycin phosphate, did not show an increased risk of infection with
ampicillin-resistant organisms.69
Current literature indicates the rates of ampicillin resistance
in pathogens causing invasive disease in infants younger than
90 days are increasing, with 36% to 60% of pathogens having
resistance.34,37,65 Since E coli represents the most common pathogen causing disease in febrile neonates, the increasing resistance to
ampicillin has sparked debate about the role of ampicillin in empirical treatment of SBI in infants. Those who advocate for it generally
do so because the principles of antibiotic stewardship would dictate that third-generation cephalosporins should not be used in this
E4
Management Recommendations
Despite all the previously described advances and developments,
management recommendations still focus on careful physical
examination, age of the infant, and clinical and laboratory criteria.
For infants younger than 28 to 30 days, the risk of SBI is still higher
and a more conservative approach can be justified. This approach
would include a complete blood cell count, urinalysis, blood and
urine cultures, and lumbar puncture. Empirical antibiotics that
include the combinations of ampicillin and gentamicin or ampicillin
and cefotaxime sodium or cefotaxime alone would all be appropriate. Maximizing the use of available viral diagnostics could preempt
many of the above recommendations if a test result is positive in
the appropriate clinical scenario (eg, positive RSV test result in an
infant in February [peak RSV season] with a toddler sibling with
respiratory tract symptoms). Because of the prolonged detection
of several respiratory viruses (rhinovirus, coronavirus) in a recent
study,58 these results may not allow for infants to be discharged
from care.
Although some are comfortable observing patients for 24 hours,
others require 72 hours for stable infants who have negative blood
culture results before discontinuing antibiotics. Recent evidence indicates if pathogenic bacteria are present, 96% of blood culture results become positive by 36 hours and 91% are positive by 24
hours.54 Therefore, observation while receiving antibiotics for 36
hours is adequate to identify nearly all infants infected with pathogenic organisms.
For infants aged 30 to 90 days, the risk of SBI declines, except
for UTIs. Prioritizing viral testing and urinalysis or urine culture may
preempt the rest of the evaluation. The empirical use of ampicillin
in this group of infants becomes even harder to justify given the lack
of cases of Listeria infection and the rising rate of ampicillin resistance. For an infant of any age who presents with signs and symptoms that suggest sepsis or a toxic appearance, a full evaluation and
prompt empirical antibiotics are indicated.
jamapediatrics.com
ARTICLE INFORMATION
Accepted for Publication: February 25, 2016.
Published Online: June 20, 2016.
doi:10.1001/jamapediatrics.2016.0596.
Author Contributions: Drs Cioffredi and Jhaveri
had full access to all the data in the study and take
responsibility for the integrity of the data and the
accuracy of the data analysis.
Study concept and design: Both authors.
Acquisition, analysis, or interpretation of data: Both
authors.
Drafting of the manuscript: Both authors.
Critical revision of the manuscript for important
intellectual content: Jhaveri.
Study supervision: Jhaveri.
Conflict of Interest Disclosures: Dr Jhaveri
reported receiving grant support from GenMark.
No other disclosures were reported.
Additional Contributions: Melissa Miller, PhD,
Department of Pathology and Laboratory Medicine,
University of North Carolina at Chapel Hill School of
Medicine, provided support for research on this
study. She was not compensated for her
contribution.
REFERENCES
1. Niska R, Bhuiya F, Xu J. National Hospital
Ambulatory Medical Care Survey: 2007 emergency
jamapediatrics.com
Conclusions
The epidemiologic features of SBI have changed significantly in the
past 20 years with the introduction and widespread use of vaccines against Hib and S pneumoniae. Management strategies must
continue to evolve to identify the few children with SBI. New diagnostic techniques, such as efficient viral testing and evaluation of
host gene expression profiling, will continue to change the landscape of the evaluation of febrile illness and may supplement
current risk stratification criteria to identify those who may be
observed in the outpatient setting safely in the near future.
E5
E6
jamapediatrics.com
jamapediatrics.com
E7